Adaptive carbon ion radiotherapy for locally advanced non‐small cell lung cancer: Organ‐sparing potential and target coverage. Issue 6 (25th March 2022)

• Record Type: Journal Article
• Authors: Jia, Shubing; Chen, Jian; Ma, Ningyi; Zhao, Jingfang; Mao, Jingfang; Jiang, Guoliang; Lu, Jiade; Wu, Kailiang
• Is Part Of: Medical physics. Volume 49:Issue 6(2022)
• Page Start: 3980
• Page End: 3989
• Publication Date: 2022-03-25
• Subjects: adaptive therapy -- carbon ion therapy -- locally advanced non‐small cell lung cancer; Medical physics -- Periodicals; Medical physics; Geneeskunde; Natuurkunde; Toepassingen; Biophysics; Periodicals; Periodicals; Electronic journals; 610.153
• DOI: 10.1002/mp.15563
• Languages: English
• ISSNs: 0094-2405

Abstract

Abstract: Background: The dose distribution of carbon ion radiotherapy (CIRT) for locally advanced non‐small cell lung cancer (LANSCLC) is highly sensitive to anatomical changes. Purpose: To demonstrate the dosimetric benefits of adaptive CIRT for LANSCLC and compare the differences between patients with and without adaptive plans based on dosimetry and clinical effect factors. Materials and methods: Of the 98 patients with LANSCLC receiving CIRT, 31 patients underwent replanning following re‐evaluations that revealed changes that would have compromised the dose coverage of the target volume or violated dose constraints. Dosimetric parameters and clinical factors were compared between patients with and without adaptive plans. Multivariate analysis identified factors influencing the adaptive planning. Results: The median number of fractions delivered using adaptive plans was eight (range: 2‐18). Adaptive plans ensured target coverage, and the maximum spinal cord dose was significantly decreased ( p = 0.02). The median reduction in the maximum spinal cord dose was 10.4 Gy (relative biological effectiveness). Patients with adaptive plans had larger tumor volumes ( p < 0.001); the median initial internal gross tumor volumes (iGTVs) of patients with adaptive and nonadaptive plans were 125.9 and 49.79 cm 3, respectively. Tumor volumes of patients with adaptive plans were altered to a greater extent ( p < 0.001); the median absolute percentage of volume changes in patients in the adaptive and in nonadaptive groups were 20.76% and 3.63%, respectively, while the median movements of iGTV centers were 5.75 and 2.44 mm, respectively. Binary logistic regression analysis revealed that the iGTV volume change and iGTV center movements were significantly different between the groups. Conclusions: An adaptive plan can effectively ensure target area coverage and protect normal tissues, especially in patients with large tumor volumes and substantial changes. iGTV volume changes and iGTV center movements are the main factors influencing adaptive planning. Weekly simulation computed tomography scans are necessary for treatment evaluation in patients with LANSCLC treated with CIRT.